[Click eStock] "IncredibleBuzz Expected to Achieve High Growth with Sunekos Distribution Rights in Asia and North America"

On July 24, GL Research analyzed IncredibleBuzz, stating that the company is expected to achieve high growth potential due to the expanding demand for biostimulators and its acquisition of Sunekos distribution rights in Asia and North America.

IncredibleBuzz has demonstrated its brand expansion capabilities in the aesthetic medical market through Motiva Korea. The company holds the Asian and North American distribution rights for the amino acid-based biostimulator "Sunekos" through a partnership with Italy's Professional Dietetics.

Park Changyoon, a researcher at GL Research, said, "Sunekos is composed only of human body components such as hyaluronic acid and amino acids, so the possibility of allergic or immune rejection reactions is extremely low." He added, "It is regarded as a next-generation solution that overcomes the limitations of existing fillers and skin boosters."

He continued, "Sunekos is commonly used in dermatology and aesthetic clinics in Europe, including the Czech Republic and the United Kingdom, as well as in other countries, and has obtained European CE certification. In addition, the company is currently working toward obtaining approval from the Ministry of Food and Drug Safety in Korea in the fourth quarter of this year, following approvals in various Asian countries. As a result, market penetration is expected to be rapid after the official launch."

Sunekos is expected to set a new standard in aesthetic medicine due to its advantages, including safety, natural improvement effects, and the minimization of side effects such as inflammation and fibrosis.

Park emphasized, "With the full-scale market entry of Sunekos after 2025, continuous performance improvement of IncredibleBuzz is anticipated."

This content was produced with the assistance of AI translation services.